Antiangiogenics in Malignant Pleural Mesothelioma: Recent Research Context
MedPage Today,
Malignant pleural mesothelioma (MPM) is a tough treatment course to navigate. If anyone knows that, it is Anne S.
Malignant pleural mesothelioma (MPM) is a tough treatment course to navigate. If anyone knows that, it is Anne S.
The addition of nintedanib (Ofev) to standard of care pemetrexed (Alimta) plus cisplatin failed to delay disease progression in…
The addition of nintedanib (Ofev) to standard of care pemetrexed (Alimta) plus cisplatin failed to delay disease progression in…
PRWeb Published 11:00 am, Friday, September 15, 2017 Nintedanib boosted mesothelioma survival by more than five months in newly-p…